Welcome to our dedicated page for Agilent Technologies SEC filings (Ticker: A), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Agilent Technologies Inc. (NYSE: A) SEC filings page provides access to the company’s official regulatory disclosures filed with the U.S. Securities and Exchange Commission. These documents include current reports on Form 8-K, annual and quarterly reports when available, and other filings that describe Agilent’s financial condition, governance changes, and capital markets activities.
Agilent uses Form 8-K to report material events such as quarterly financial results and executive leadership changes. For example, the company has filed 8-Ks to furnish earnings press releases for fiscal quarters, explaining revenue, net income, segment performance for the Life Sciences and Diagnostics Markets Group, Agilent CrossLab Group, and Applied Markets Group, and to discuss the use of non-GAAP financial measures. Separate 8-K filings describe the resignation of a chief financial officer, the appointment of an interim CFO, and the subsequent appointment of a new senior vice president and chief financial officer, including related compensation and equity awards.
Through its filings, Agilent explains why it presents non-GAAP financial information, stating that these measures are intended to provide meaningful supplemental insight into operational performance and to facilitate comparisons with historical results and other companies. The company notes that non-GAAP figures exclude items such as restructuring and amortization, are monitored alongside GAAP results, and may differ from similar measures used by other issuers.
On Stock Titan, these SEC filings are updated from EDGAR and can be paired with AI-powered summaries that highlight key points, such as changes in leadership, segment trends, and the rationale behind non-GAAP adjustments. Users can quickly locate current reports, review disclosures about executive appointments and compensation arrangements, and understand how Agilent communicates its financial performance and governance decisions to regulators and investors.
Agilent Technologies, Inc. officer and Senior Vice President reported a routine equity transaction on Form 4. On 11/26/2025, the reporting person surrendered 300 shares of Agilent common stock to the company at a price of $154.37 per share to cover tax liabilities arising from the vesting of restricted stock units under Rule 16b-3. After this tax-related surrender, the reporting person beneficially owned 14,207.2469 shares of Agilent common stock, held directly.
Agilent Technologies executive reports small stock disposition for tax withholding
A Senior Vice President of Agilent Technologies, Inc. reported a routine share disposition related to equity compensation. On 11/26/2025, the executive surrendered 430 shares of Agilent common stock at a reported price of $154.37 per share, coded as an "F" transaction, meaning the shares were withheld to cover taxes on vesting restricted stock units. After this transaction, the executive beneficially owns 14,262 shares of Agilent common stock directly. No derivative securities transactions were reported in this filing.
Agilent Technologies executive Rodney Gonsalves, Vice President and Corporate Controller, reported multiple stock transactions in Agilent Technologies, Inc. common stock. On 11/26/2025, he sold 3,000 shares at a weighted average price of $154.9853 per share, with individual sale prices ranging from $154.98 to $155.05. He also surrendered 119 shares to Agilent to cover tax liabilities related to the vesting of restricted stock units.
That same day, Gonsalves reported several gift-related movements: transfers coded as gifts involving 200 shares connected to the Gonsalves Family Charitable Gift Fund and indirect holdings in the Gonsalves Trust. After these transactions, he directly owned 31,526.6872 shares of Agilent common stock and held 40.192 shares indirectly through the Gonsalves Trust.
Agilent Technologies reported an insider equity transaction by a senior vice president. On 11/26/2025, the executive surrendered 332 shares of Agilent common stock to the company to cover tax liabilities arising from the vesting of restricted stock units, as permitted under Rule 16b-3. The shares were valued at $154.37 each for this tax withholding transaction. After this adjustment, the reporting person directly beneficially owns 12,203.056 shares of Agilent common stock.
Agilent Technologies (A) filed a Form 144 indicating a planned sale of 3,000 shares of its common stock through Fidelity Brokerage Services LLC on 11/26/2025 on the NYSE, with an aggregate market value of 464,956.00. The notice states that the issuer had 283,500,427 shares of common stock outstanding, providing context for the size of the planned sale.
The shares to be sold were acquired over time through employee stock purchase plan (ESPP) purchases made for cash and through restricted stock that vested as compensation between 10/31/2022 and 11/22/2024. The person selling represents that they are not aware of any material adverse, non-public information about the issuer’s current or prospective operations.
Agilent Technologies, Inc. (ticker: A) reported an insider equity transaction by a Senior Vice President. On 11/21/2025, the executive surrendered 67 shares of Agilent common stock to the company at a price of $151.25 per share. This was done to cover tax liabilities arising from the vesting of restricted stock units under Rule 16b-3, which governs certain insider transactions. After this tax-related share surrender, the executive beneficially owned about 11,847.0318 shares of Agilent common stock directly.
Agilent Technologies, Inc. (A) reported an insider transaction by a Senior Vice President. On 11/21/2025, the executive surrendered 75 shares of common stock to Agilent Technologies, Inc. to cover tax liabilities arising from the vesting of restricted stock units, as allowed under Rule 16b-3. After this tax withholding, the executive directly beneficially owned 26,873.9266 shares of common stock and indirectly owned 2,607.6856 shares through a spouse.
Agilent Technologies, Inc. (ticker: A) reported an insider equity transaction by its President and CEO, who is also a director. On 11/21/2025, the executive surrendered 541 shares of common stock to Agilent at a price of $151.25 per share.
The filing explains that these shares were surrendered to the company to satisfy tax liabilities arising from the vesting of restricted stock units under Rule 16b-3. After this tax-related share surrender, the executive directly beneficially owns 68,487 shares of Agilent common stock.
Agilent Technologies (A) reported an insider equity transaction by its Senior Vice President. On 11/21/2025, the executive surrendered 113 shares of common stock at a price of $151.25 per share to Agilent Technologies, Inc. to cover tax liabilities arising from the vesting of restricted stock units, as permitted under Rule 16b-3. After this tax-related share surrender, the reporting person beneficially owned 14,692 shares of Agilent common stock, held directly.
Agilent Technologies (ticker: A) officer reports routine tax share surrender. On 11/21/2025, the company’s V.P., Corporate Controller reported a Form 4 transaction coded “F,” meaning 138 shares of common stock were surrendered to Agilent Technologies, Inc. to cover taxes due on the vesting of restricted stock units. After this transaction, the reporting person beneficially owned 34,845.6872 shares of Agilent common stock directly and 40.192 shares indirectly through the Gonsalves Trust, for which Rodney and Rochelle Gonsalves serve as trustees. This filing records an administrative tax-withholding event rather than an open-market trade.